Biden's Cancer Moonshot: Pushing Boundaries in Oncology

President Joe Biden, no longer seeking a second term, is focusing on his 'moonshot' initiative to reduce cancer deaths. He visited Tulane University to promote the latest in scanning technology and announced $150 million in awards to researchers. Experts say significant progress is attainable with proper funding.

President Joe Biden is turning his attention to his 'moonshot' policy initiative, which aims to drastically cut cancer deaths now that he is not pursuing a second term. On Tuesday, Biden, accompanied by First Lady Jill Biden, visited Tulane University in New Orleans to promote advancements in cancer treatment technology.

During their visit, the Bidens toured medical facilities that benefit from federal funding for cancer research. At Tulane, researchers demonstrated cutting-edge scanning technology designed to differentiate between healthy and cancerous cells in real-time during surgeries. The visit also included the announcement of $150 million in awards from the Advanced Research Projects Agency for Health to support cancer research teams nationwide.

Biden emphasized the urgency of the initiative, expressing optimism about the potential for technological breakthroughs to make a significant impact on cancer treatment. Experts agree that with sufficient investment, these goals are achievable. Cancer remains the second leading cause of death in the US, with this year alone seeing an estimated 2 million new diagnoses.

(With inputs from agencies.)